A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

NCT02555878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

841

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Rivaroxaban
DRUG: Placebo

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]